Form 6-K Itau Unibanco Holding For: Nov 03 Nov 4, 2026 07:42AM UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 6-KReport of Foreign IssuerPursuant to Rule 13a-16 or 15d-16of the Securities Exchange Act of 1934For the month of November, 2026Comission File Number: 001-15276Itaú Unibanco Holding S.A.(Exact name of registrant as specified in its charter)Itaú Unibanco Holding S.A.(Translation of Registrant’s Name into English)Praça Alfredo Egydio de Souza Aranha, 100 - Torre ConceiçãoCEP 04344-902 São... (continue reading...)
Form 10-Q NewAmsterdam Pharma Co For: Sep 30 Nov 4, 2026 07:40AM ... (continue reading...)
Form 8-K Spectrum Brands Holdings For: Nov 04 Nov 4, 2026 07:40AM false 0000109177 0000109177 2026-11-04 2026-11-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

____________________________

 

FORM 8-K

____________________________

 

... (continue reading...)


Form 8-K Madison Square Garden For: Nov 04 Nov 4, 2026 07:40AM FALSE000195207300019520732026-11-042026-11-04UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPursuant to Section 13 OR 15(d)of The Securities Exchange Act of 1934Date of Report (Date of earliest event reported): November 4, 2026 MADISON SQUARE GARDEN ENTERTAINMENT CORP. (Exact name of registrant as specified in its charter)Nevada001-4162792-0318813(State or other jurisdictionof incorporation)(CommissionFile Number)(IRS... (continue reading...)
Form 8-K Royalty Pharma plc For: Nov 04 Nov 4, 2026 07:39AM FALSE000180276800018027682026-11-042026-11-04UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 OR 15(d)of The Securities Exchange Act of 1934Date of Report (Date of earliest event reported): November 4, 2026Royalty Pharma plc(Exact Name of Registrant as Specified in its Charter)England and Wales001-3932998-1535773(State or other jurisdictionof incorporation)(CommissionFile Number)(I.R.S.Identification No.)... (continue reading...)

More SEC Filings

View Older Stories

Nov 4, 2026 07:36AM Form 10-Q NCR Atleos Corp For: Sep 30
Nov 4, 2026 07:35AM Form 8-K NewAmsterdam Pharma Co For: Nov 04
Nov 4, 2026 07:35AM Form 8-K Fidelity National Inform For: Nov 04
Nov 4, 2026 07:35AM Form 8-K FOSTER L B CO For: Nov 02
Nov 4, 2026 07:34AM Form 8-K Medline Inc. For: Nov 04
Nov 4, 2026 07:34AM Form 8-K SCOTTS MIRACLE-GRO CO For: Nov 04
Nov 4, 2026 07:33AM Form 8-K NCR Atleos Corp For: Nov 04
Nov 4, 2026 07:31AM Form 10-Q VISHAY INTERTECHNOLOGY For: Oct 03
Nov 4, 2026 07:31AM Form 10-Q Latham Group, Inc. For: Sep 26
Nov 4, 2026 07:31AM Form 8-K Riot Platforms, Inc. For: Oct 29
Nov 4, 2026 07:31AM Form 10-Q Dine Brands Global, Inc. For: Sep 27
Nov 4, 2026 07:31AM Form 8-K WESTLAKE CORP For: Nov 04
Nov 4, 2026 07:31AM Form 8-K Westlake Chemical Partne For: Nov 04
Nov 4, 2026 07:31AM Form 6-K JD.com, Inc. For: Nov 04
Nov 4, 2026 07:31AM Form 10-Q Rapport Therapeutics, For: Sep 30
Nov 4, 2026 07:31AM Form 8-K Polar Power, Inc. For: Nov 04
Nov 4, 2026 07:30AM Form 8-K Tronox Holdings plc For: Nov 03
Nov 4, 2026 07:30AM Form 10-Q Viridian Therapeutics, For: Sep 30
Nov 4, 2026 07:30AM Form 8-K ARROWHEAD PHARMACEUTICAL For: Nov 04
Nov 4, 2026 07:30AM Form 6-K dLocal Ltd For: Nov 04
Nov 4, 2026 07:30AM Form 4 Seaport Therapeutics, For: Nov 03 Filed by: Torres Denice
Nov 4, 2026 07:29AM Form 6-K Itau Unibanco Holding For: Nov 03
Nov 4, 2026 07:29AM Form 10-Q uniQure N.V. For: Sep 30
Nov 4, 2026 07:23AM Form 4 Estrella Immunopharma, For: Nov 02 Filed by: Pussinen Cynthia
Nov 4, 2026 07:22AM Form 8-K NATURAL RESOURCE PARTNER For: Nov 04
Nov 4, 2026 07:21AM Form 8-K CS Disco, Inc. For: Nov 04
Nov 4, 2026 07:21AM Form 8-K VISHAY INTERTECHNOLOGY For: Nov 04
Nov 4, 2026 07:19AM Form 10-Q Shoals Technologies Grou For: Sep 30
Nov 4, 2026 07:18AM Form 6-K GLOBALFOUNDRIES Inc. For: Sep 30
Nov 4, 2026 07:17AM Form 8-K Array Technologies, Inc. For: Nov 04
Nov 4, 2026 07:17AM Form 8-K Kyndryl Holdings, Inc. For: Nov 04
Nov 4, 2026 07:16AM Form 10-Q Odyssey Therapeutics, For: Sep 30
Nov 4, 2026 07:15AM Form 10-Q Q32 Bio Inc. For: Sep 30
Nov 4, 2026 07:15AM Form 8-K Dine Brands Global, Inc. For: Nov 04
Nov 4, 2026 07:15AM Form 10-Q LIFECORE BIOMEDICAL, For: Sep 30
Nov 4, 2026 07:14AM Form 8-K SelectQuote, Inc. For: Nov 04
Nov 4, 2026 07:14AM Form 8-K LIFECORE BIOMEDICAL, For: Nov 04
Nov 4, 2026 07:13AM Form 6-K Brookfield Renewable For: Sep 30
Nov 4, 2026 07:13AM Form 10-Q FISERV INC For: Sep 30
Nov 4, 2026 07:12AM Form 8-K GERON CORP For: Nov 04
Nov 4, 2026 07:12AM Form 8-K Rapport Therapeutics, For: Nov 04
Nov 4, 2026 07:11AM Form 8-K Datadog, Inc. For: Nov 04
Nov 4, 2026 07:11AM Form 8-K Viridian Therapeutics, For: Nov 04
Nov 4, 2026 07:11AM Form 10-Q MoonLake Immunotherapeut For: Sep 30
Nov 4, 2026 07:11AM Form 6-K Itau Unibanco Holding For: Nov 03
Nov 4, 2026 07:10AM Form 8-K uniQure N.V. For: Nov 04
Nov 4, 2026 07:10AM Form 8-K Shoals Technologies Grou For: Nov 04
Nov 4, 2026 07:09AM Form 10-Q Pharmaceutical Resource For: Sep 30
Nov 4, 2026 07:09AM Form 6-K GLOBALFOUNDRIES Inc. For: Sep 30
Nov 4, 2026 07:09AM Form 6-K Brookfield Renewable For: Sep 30
View Older Stories